Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Deferred Taxes (2016 - 2025)

Utah Medical Products has reported Deferred Taxes over the past 15 years, most recently at -$18000.0 for Q4 2025.

  • Quarterly results put Deferred Taxes at -$18000.0 for Q4 2025, down 131.03% from a year ago — trailing twelve months through Dec 2025 was -$659000.0 (down 83.57% YoY), and the annual figure for FY2025 was -$659000.0, down 83.57%.
  • Deferred Taxes for Q4 2025 was -$18000.0 at Utah Medical Products, up from -$281000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for UTMD hit a ceiling of $230000.0 in Q2 2021 and a floor of -$409000.0 in Q4 2023.
  • Median Deferred Taxes over the past 5 years was -$143000.0 (2022), compared with a mean of -$110200.0.
  • Biggest five-year swings in Deferred Taxes: surged 1233.33% in 2021 and later plummeted 6300.0% in 2024.
  • Utah Medical Products' Deferred Taxes stood at $68000.0 in 2021, then plummeted by 88.24% to $8000.0 in 2022, then tumbled by 5212.5% to -$409000.0 in 2023, then surged by 114.18% to $58000.0 in 2024, then plummeted by 131.03% to -$18000.0 in 2025.
  • The last three reported values for Deferred Taxes were -$18000.0 (Q4 2025), -$281000.0 (Q3 2025), and -$151000.0 (Q2 2025) per Business Quant data.